Acute cardiovascular toxicity induced by an adenosine agonist-antihypertensive in beagles.
An adenosine agonist, designated chemically as (R)-N-(2,3-dihydro-1H-inden- 1-yl) adenosine, or CI-947, was administered to 3 male and 3 female beagles in oral doses of 5 mg/kg body weight. Multiple episodes of arrhythmia were recorded electrocardiographically with Holter monitors in 2 males and 2 females monitored up to 48 hr. One male and 1 female were necropsied at 24 hr and the remaining dogs were necropsied at 48 hr post-dosing. At 48 hr, multifocal perivascular epicardial and myocardial hemorrhage was noted grossly in 1 female. Microscopic coronary arterial alterations were present in all treated dogs irrespective of the occurrence of arrhythmias. At 24 hr, proteinic material and red cells were present in the media accompanied by minimal adventitial accumulation of neutrophils. At 48 hr, coronary arterial lesions progressed to media vacuolation, transmural necrosis, and perivascular accumulation of neutrophils. Ultrastructural alterations included: endothelial retraction, subendothelial accumulation of fibrin and platelets, necrosis of smooth muscle cells, and mural infiltration of granulocytes and monocytes. Coronary vascular injury may be due to altered hemodynamics associated with the coronary vasodilator properties of adenosine agonist compounds.
Metz
A L
AL
Warner-Lambert Co., Parke-Davis Pharmaceutical Research Division, Ann Arbor, Michigan 48105.
Dominick
M A
MA
Suchanek
G
G
Gough
A W
AW
D000241:Adenosine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000502:physiology* / Q000633:toxicity; D000284:Administration, Oral; D000818:Animals; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000633:toxicity*; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D001158:Arteries / Q000187:drug effects / Q000473:pathology / Q000648:ultrastructure; D002319:Cardiovascular System / Q000187:drug effects* / Q000473:pathology; D003331:Coronary Vessels / Q000187:drug effects / Q000473:pathology / Q000648:ultrastructure; D004285:Dogs; D004562:Electrocardiography; D005260:Female; D008297:Male; D008854:Microscopy, Electron; D009336:Necrosis; D014664:Vasodilation / Q000187:drug effects
D000959:Antihypertensive Agents; C071201:N-(2,3-dihydro-1H-inden-1-yl)adenosine; D000241:Adenosine